Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: Evaluation of risk factors

Infection

Volumn 38, Issue 5, 2010, Pages 381-385

  Reinheimer, C ^a   Allwinn, R ^a   Doerr, H W ^a   Wittek, M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Parvovirus B19; Risk groups; Seroprevalence; University hospital Frankfurt am Main

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; GERMANY; GYNECOLOGIC DISEASE; HEMOPHILIA; HOSPITAL ADMISSION; HUMAN; HUMAN PARVOVIRUS B19; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; POPULATION RESEARCH; PREGNANT WOMAN; SEROEPIDEMIOLOGY; SEROPREVALENCE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; GERMANY; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 77957657939     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0035-y     Document Type: Article

References (28)

1. KE Brown 2000 Haematological consequences of parvovirus B19 infection Baillieres Best Pract Res Clin Haematol 13 245 259 1:STN:280: DC%2BD3cvis12qsA%3D%3D 10942624
2. Yu MY et al. Parvovirus B19 transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion. 2010. doi: 10.1111/j.1537-2995.2010.02591.x.
3. Choudhury N, Adke S. Transfusion transmitted diseases. Indian J Pediatr. 2010;68:951-8.
4. M Schiesser, et al. 2009 Discordant outcomes in a case of parvovirus b19 transmission into both dichorionic twins Twin Res Hum Genet 12 175 179 10.1375/twin.12.2.175 19335188
5. K Hokynar, et al. 2004 Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests J Clin Microbiol 42 2013 2019 1:CAS:528:DC%2BD2cXkvFOjtr4%3D 10.1128/JCM.42.5.2013-2019.2004 15131163
6. P Sharma, et al. 2006 Parvovirus B-19 induced acute red cell aplasia in patients with chronic lymphocytic leukemia and neurofibromatosis type-1 Hematology 11 257 259 10.1080/10245330600954171 17178664
7. D Peterlana, et al. 2006 Serologic, molecular detection of human Parvovirus B19 infection Clin Chim Acta 372 14 23 1:CAS:528:DC%2BD28XovVSks7c%3D 10.1016/j.cca.2006.04.018 16765338
8. S Aslanidis, et al. 2008 Parvovirus B19 infection, systemic lupus erythematodes activation of an aberrant pathway? Eur J Intern Med 19 314 318 10.1016/j.ejim.2007.09.013 18549931
9. CK Sasidharan, et al. 2009 Red baby syndrome a new disease due to parvovirus B-19 observed in Kerala Indian J Pediatr 76 309 312 1:STN:280:DC%2BD1M3lvFymug%3D%3D 10.1007/s12098-009-0057-6 19347671
10. Modrow S. Kapitel Parvovirus in Doerr HW, Gerlich WH, Medizinische Virologie, 2. Aufl. 2010. Stuttgart: Thieme.
11. JT Servey, et al. 2007 Clinical presentations of parvovirus B19 infection Am Fam Physician 75 373 376 17304869
12. T Schenk, et al. 2009 High prevalence of human Parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy J Clin Microbiol 47 106 110 1:CAS:528:DC%2BD1MXpsFarurk%3D 10.1128/JCM.01672-08 19005147
13. D Vassilopoulos, et al. 2008 Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations Arthritis Res Ther 10 215 10.1186/ar2480 18828883
14. B Weissbrich, et al. 2007 Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis Arthritis Res Ther 9 R82 10.1186/ar2281 17760961
15. A Lundqvist, et al. 2005 High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients J Clin Virol 33 71 74 1:CAS:528:DC%2BD2MXis1Knur4%3D 10.1016/j.jcv.2004.11.011 15797368
16. F Forestier, et al. 1999 Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis Br J Haematol 104 925 927 1:STN:280:DyaK1M3gs1Kkuw%3D%3D 10.1046/j.1365-2141.1999.01241.x 10192461
17. Kessler CM. New perspectives in hemophilia treatment. Hematology Am Soc Hematol Educ Program. 2005:429-35.
18. L Sung, et al. 2009 Infections and associations with different intensity of chemotherapy in children with acute myeloid leukemia Cancer 115 1100 1108 10.1002/cncr.24107 19156894
19. M Debled, et al. 2007 Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis Br J Cancer 97 1642 1647 1:CAS:528:DC%2BD2sXhsVSrsLzN 10.1038/sj.bjc.6604094 18000502
20. KSR Massaro, et al. 2007 Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults BMC Infect Dis 7 137 10.1186/1471-2334-7-137 18034890
21. BV Fortner, et al. 2004 Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities BMC Cancer 4 22 10.1186/1471-2407-4-22 15153249
22. C Röhrer, et al. 2008 Seroprevalence of parvovirus B19 in the German population Epidemiol Infect 136 1564 1575 10.1017/S0950268807009958 18198003
23. M Enders 2007 Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany Epidemiol Infect 135 563 569 1:STN:280:DC%2BD2s3jsVGktg%3D%3D 10.1017/S095026880600731X 17064457
24. E Manaresi, et al. 2004 Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus b19 in Italian blood donors Epidemiol Infect 132 857 862 1:STN:280:DC%2BD2crgsVSrtQ%3D%3D 10.1017/S0950268804002389 15473148
25. BJ Cohen 1988 The prevalence of antibody to human parvovirus B 19 in England and Wales J Med Microbiol 25 151 153 1:STN:280:DyaL1c7hvVyhsg%3D%3D 10.1099/00222615-25-2-151 3339634
26. ED Heegaard, et al. 2002 Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals J Clin Microbiol 40 933 936 1:CAS:528:DC%2BD38XisVKrs7c%3D 10.1128/JCM.40.3.933-936.2002 11880419
27. Y Matsunaga, et al. 1994 Low prevalence of antibody to human parvovirus B19 in Singapore Epidemiol Infect 113 537 540 1:STN:280:DyaK2M%2FoslOisA%3D%3D 10.1017/S0950268800068552 7995362
28. Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung ("Mutterschafts-Richtlinien") in der Fassung vom 10. Dezember 1985 (veröffentlicht im Bundesanzeiger Nr. 60 a vom 27. März 1986) zuletzt geändert am 6. August 2009, veröffentlicht im Bundesanzeiger 2009, Nr. 174: S. 3 921 in Kraft getreten am 19. November 2009.